⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4552218 | 0.72 | — | — | |
| SCHEMBL17541825 | 0.72 | — | — | |
| SCHEMBL5612155 | 0.71 | ALDH1A1 (0.31) | — | |
| SCHEMBL3763913 | 0.69 | — | — | |
| SCHEMBL15676669 | 0.69 | — | — | |
| SCHEMBL2185408 | 0.67 | — | — | |
| SCHEMBL5134648 | 0.67 | ALDH1A1 (0.30) | — | |
| SCHEMBL1916567 | 0.67 | — | — | |
| SCHEMBL3593911 | 0.67 | — | — | |
| SCHEMBL11565615 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1865968-A2 | TOPICAL FORMULATIONS OF BORINIC ACID ANTIBODIES AND THEIR METHODS OF USE | Anacor Pharmaceuticals, Inc. (US) | 2007-12-19 | — | — | EP | claimed |
| US-20060217347-A1 | Topical formulations of borinic acid antibiotics and their methods of use | ANACOR PHARMACEUTICALS, INC. | 2006-09-28 | — | — | US | claimed |
| WO-2006102604-A2 | TOPICAL FORMULATIONS OF BORINIC ACID ANTIBODIES AND THEIR METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2006-09-28 | — | — | WO | claimed |
| EP-2437854-B1 | COMPOSITIONS COMPRISING BORINIC ESTERS | COLGATE PALMOLIVE CO (US) | 2018-08-08 | — | — | EP | disclosed |
| US-8852559-B2 | Borinic compositions | COLGATE-PALMOLIVE COMPANY (US) | 2014-10-07 | — | — | US | disclosed |
| EP-2437855-A2 | BORINIC COMPOSITIONS | Colgate-Palmolive Company (US) | 2012-04-11 | — | — | EP | disclosed |
| EP-2437854-A2 | BORINIC COMPOSITIONS | Colgate-Palmolive Company (US) | 2012-04-11 | — | — | EP | disclosed |
| US-20120064017-A1 | BORINIC COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120052025-A1 | BORINIC COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2012-03-01 | — | — | US | disclosed |
| WO-2010141693-A2 | BORINIC COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2010-12-09 | — | — | WO | disclosed |
| WO-2010141694-A2 | BORINIC COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2010-12-09 | — | — | WO | disclosed |
| US-20080233127-A1 | IMIDAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS PI3 KINASE AND MTOR INHIBITORS | WYETH (US) | 2008-09-25 | — | — | US | disclosed |
| EP-1865968-A2 | TOPICAL FORMULATIONS OF BORINIC ACID ANTIBODIES AND THEIR METHODS OF USE | Anacor Pharmaceuticals, Inc. (US) | 2007-12-19 | — | — | EP | disclosed |
| US-20060217347-A1 | Topical formulations of borinic acid antibiotics and their methods of use | ANACOR PHARMACEUTICALS, INC. | 2006-09-28 | — | — | US | disclosed |
| WO-2006102604-A2 | TOPICAL FORMULATIONS OF BORINIC ACID ANTIBODIES AND THEIR METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2006-09-28 | — | — | WO | disclosed |